Micro- and Nanoparticles for Treating Cardiovascular Disease
S Suarez1, A Almutairi2, K L Christman1
1Department of Bioengineering and Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, California, United States.
Insights
Micro- and nano-particle therapies show promise for treating cardiovascular diseases like myocardial infarction (MI) and peripheral artery disease (PAD) by delivering therapeutic agents to injured tissues.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiovascular diseases, such as myocardial infarction (MI) and peripheral artery disease (PAD), affect millions, with current treatments inadequately restoring blood flow or repairing ischemic damage.
- Vessel occlusion leads to ischemic injury in the heart and skeletal muscle, necessitating advanced therapeutic strategies.
Purpose of the Study:
- To review existing particle-based therapies for treating myocardial infarction (MI) and peripheral artery disease (PAD).
- To explore the potential of micro- and nano-particles as delivery vehicles for therapeutic agents in cardiovascular disease treatment.
Main Methods:
- Review of current literature on particle-based therapies for MI and PAD.
- Analysis of micro- and nano-particle formulations and their delivery mechanisms (direct injection vs. intravenous).
Main Results:
- Micro- and nano-particles are being developed as delivery systems for growth factors, enzymes, and small molecules.
- These particles offer sustained therapeutic stimulus at injury sites.
- Particle formulations allow for targeted delivery via direct injection or accumulation after intravenous administration.
Conclusions:
- Particle-based therapies represent a promising approach to address the limitations of current treatments for MI and PAD.
- Further development of micro- and nano-particle delivery systems could significantly improve outcomes for patients with cardiovascular diseases.
Abstract:
Cardiovascular disease, including myocardial infarction (MI) and peripheral artery disease (PAD), afflicts millions of people in Unites States. Current therapies are insufficient to restore blood flow and repair the injured heart or skeletal muscle, respectively, which is subjected to ischemic damage following vessel occlusion. Micro- and nano-particles are being designed as delivery vehicles for growth factors, enzymes and/or small molecules to provide a sustained therapeutic stimulus at the injured tissue. Depending on the formulation, the particles can be injected directly into the heart or skeletal muscle, or accumulate at the site of injury following an intravenous injection. In this article we review existing particle based therapies for treating MI and PAD.
Related Concept Videos
01:26Atherosclerosis III: Management
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications